This SARS-CoV-2 lateral flow assay detects total antibodies (IgA/IgG/IgM) against SARS-CoV-2 in human blood and serum. SARS-CoV-2 antibodies in the specimen bind to SARS-CoV-2 antigen-coated gold nanoparticles (AuNP) forming AuNP-complexes.
HS300220 - Vaccines; for human medicine
| Product or Service Certification |
|---|
Company Name: Lifeassay Diagnostics PTY LTD
Company Address: 7 Bell Crescent, Westlake Business Park, 7945, South Africa
Company General Phone: +27 21 788 6989
Company General Mail: info@lifeassay.com
Company Website: www.lifesadx.com
Key Contact: Louis Roux
Key Contact Phone: +27 83 267 2067
Key Contact General Mail: info@lifeassay.com
Incorporation Date: October 01, 2009
BEE: Not BEE Eligible
Woman-Owned: No
Company Size: 10 – 20
Distribution: Other
Company Overview: At LifeSADX we believe that all great companies had small beginnings. Therefore the smallest customer is of great importance to us. We strive to ensure that our response time is the shortest possible, that information supplied is accurate and precise, and that contact with customers remains highly professional at all times. Programmes for ongoing customer satisfaction and customer support take the highest priority and are measured continuously to ensure QUALITY is delivered IN FULL and ON TIME. LifeSADX’s manufacturing facilities are based in Cape Town, South Africa. The Cape Town plant is ISO13485:2016 certified
Year Started Exporting: |
2010 |
Countries Currently Exporting to: |
Botswana, Dominican Republic, Egypt, France, Germany, Ghana, Kenya, Lesotho, Malawi, Mozambique, Pakistan, Zimbabwe |
Countries Hoping to Export to: |
Japan, United States |
Registered Under the Following Trade Agreements: |
None |
